Ebsteins anomaly of the tricuspid valve epidemiology and demographics
Ebsteins anomaly of the tricuspid valve Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Ebsteins anomaly of the tricuspid valve epidemiology and demographics On the Web | |
American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve epidemiology and demographics | |
FDA on Ebsteins anomaly of the tricuspid valve epidemiology and demographics | |
CDC on Ebsteins anomaly of the tricuspid valve epidemiology and demographics | |
Ebsteins anomaly of the tricuspid valve epidemiology and demographics in the news | |
Blogs on Ebsteins anomaly of the tricuspid valve epidemiology and demographics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]
Overview
Ebstein's anomaly is a rare congenital heart diseasespace and makes up only 0.5% of all congenital heart disease. It is observed in 5/100,000 newborns in the United States with no gender predilection, but a higher incidence in Caucasians.
Epidemiology and Demographics
Incidence
In United States, the incidence of Ebstein's anomaly of the tricuspid valve is 5 per 100,000 patients.
Gender
Males = females.
Race
More common in white children.